Read the podcast transcript here.

In the inaugural "Bladder Cancer Matters" podcast, host Rick Bangs interviews Dr. Ashish Kamat about the state of BCG in bladder cancer treatment.  Dr. Kamat is a Professor (Tenure) of Urology and Director of Urologic Oncology Fellowship at MD Anderson Cancer Center, and a graduate of the AUA Leadership Program.  Dr. Kamat also serves on BCAN's Scientific Advisory Board.

In this episode, Rick and Dr. Kamat discuss what BCG is, how it is used, why there is a BCG shortage and what some therapeutic alternatives are.

Dr. Kamat can be found on Twitter at @UroDocAsh.

This episode is sponsored by FerGene,  a new gene therapy company dedicated to creating and delivering innovative solutions for bladder cancer.